ロード中...
Gastric mucosal protection with selective inhibition of thromboxane synthesis.
Because thromboxane synthesis enhances gastric mucosal damage we have investigated whether the thromboxane synthesis inhibitor dazmegrel might be protective to the mucosa. Dazmegrel at a dose of 1 and 5 mg per rat (4.8 and 23.8 mg/kg) significantly reduced the damage caused by acidified taurocholate...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1987
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1432886/ https://ncbi.nlm.nih.gov/pubmed/3474195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|